Literature DB >> 17315619

Troponin I release at rest and after exercise in patients with hypertrophic cardiomyopathy and the effect of betablockade.

Gheorghe A M Pop1, Etienne Cramer, Janneke Timmermans, Hans Bos, Freek W A Verheugt.   

Abstract

PURPOSE OF THE WORK: In patients with hypertrophic cardiomyopathy ischemia may occur due to massive heart weight, myocyte disarray or small vessel disease. We detected elevated troponin levels in some of these patients and hypothesized that troponin release would rise after exercise and diminish after betablockade. METHODS AND
RESULTS: In 5 of 7 young patients (6 males) with hypertrophic cardiomyopathy and no overt coronary artery disease we found elevated troponin levels after physical exercise; the peak was between 6 and 9 hours and levels returned to pre-exercise values within 24 hours. Troponin release was consistently diminished after use of a betablocker.
CONCLUSIONS: Increased troponin release may be present in patients with hypertrophic cardiomyopathy and is temporarily enhanced by exercise and diminishes with betablockade.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17315619

Source DB:  PubMed          Journal:  Arch Cardiol Mex        ISSN: 1665-1731


  5 in total

1.  Role of cardiac magnetic resonance in differentiating between acute coronary syndrome and apical hypertrophic cardiomyopathy.

Authors:  Renata Rajtar-Salwa; Paweł Petkow-Dimitrow; Tomasz Miszalski-Jamka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-11-17       Impact factor: 1.426

2.  Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014.

Authors:  Renata Rajtar-Salwa; Rafał Hładij; Paweł Petkow Dimitrow
Journal:  Dis Markers       Date:  2017-11-20       Impact factor: 3.434

3.  The diagnostic role of cardiac magnetic resonance used "first and last time in life" in a patient with a suspected dilated phase of hypertrophic cardiomyopathy.

Authors:  Rafał Hładij; Renata Rajtar-Salwa; Artur Dziewierz; Paweł Petkow-Dimitrow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-05-30       Impact factor: 1.426

4.  Exercise and myocardial injury in hypertrophic cardiomyopathy.

Authors:  G Etienne Cramer; D H Frank Gommans; Hendrik-Jan Dieker; Michelle Michels; Freek Verheugt; Menko-Jan de Boer; Jeannette Bakker; Michael A Fouraux; Janneke Timmermans; Marcel Kofflard; Marc Brouwer
Journal:  Heart       Date:  2020-01-30       Impact factor: 5.994

5.  Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014).

Authors:  Rafał Hładij; Renata Rajtar-Salwa; Paweł Petkow Dimitrow
Journal:  Cardiovasc Ultrasound       Date:  2017-09-13       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.